Research Articles
Unlocking the Next Generation of Cancer Therapy: The Era of Tunable Drug Conjugates
Explore the revolutionary Tunable Drug Conjugate platform - a modular approach to cancer therapy that offers precise control over drug delivery and reduced side effects.
Tiny Trojan Horses: Engineering Bacteria to Deliver a Cancer-Killing One-Two Punch
Discover how scientists are engineering attenuated Listeria bacteria to deliver targeted chemotherapy drugs directly to cancer cells using revolutionary click chemistry.
Polymer Warriors: How Molecular Delivery Systems Could Revolutionize Cancer Therapy
Exploring how HPMA copolymer drug bioconjugates can deliver Bcl-2 inhibitor HA14-1 to revolutionize cancer treatment through targeted therapy.
Intelligent Delivery: How Signal-Responsive Carriers Are Revolutionizing Cancer Therapy
Explore how intracellular signal-responsive carriers are transforming cancer gene therapy through precise tumor targeting and reduced side effects.
Silent Assassins: How Cyclopeptidic Prodrugs are Revolutionizing Cancer Therapy
Discover how cyclopeptidic-based protease-sensitive photosensitizer prodrugs are transforming cancer treatment through precision targeting and light-activated therapy.
Beyond Platinum: The New Generation of Metal-Based Cancer Therapies
Exploring the promising role of non-platinum metal complexes like ruthenium and gold in cancer therapy, their mechanisms, and clinical progress.
The Shape-Shifters Within: How Molecular Contortions Are Revolutionizing Cancer Drug Design
Exploring how molecular conformation dynamics are transforming cancer drug design, with focus on M1 aminopeptidase inhibitors.
Light Warriors: The Fluorescent Molecule That Targets Cancer with Deadly Precision
Discover the groundbreaking binary BMVC-porphyrin photosensitizer that combines cancer detection and treatment in a single molecular system.
The Molecular Trojan Horse: A Triple-Threat Weapon Emerges in the Cancer Fight
Exploring Biotin-SN38-Valproic Acid Conjugates as a targeted cancer therapy approach combining chemotherapy, epigenetic modulation, and precise delivery.
Unlocking Cancer's Defenses: New Combo Therapy Shows Striking Promise Against Aggressive Tumors
Novel DNA-PK inhibitor combined with radiation therapy demonstrates potent synergy against glioblastoma and lung cancer in preclinical studies.